08.17.23
Intricon, a Minnesota based medical device manufacture, plans to open the first facility dedicated to the development and manufacturing of sensor-driven medical devices. The facility will be located in Costa Rica and will produce microelectronics, biosensors, and electromagnetic navigation (EMN) sensors.
“Companies need the increased capacity and deep expertise Intricon brings to help them meet the growing demand for sensor-driven devices as non-invasive, data-driven healthcare becomes a reality. When it comes to these devices, Intricon has done it all and seen it all, so we can reduce and eliminate risk while accelerating commercialization,” said CEO Scott Longval.
The facility is scheduled to open in 2024 and will be housed in Costa Rica’s extension zone for medical device infrastructure, Evolution Free Zone, Grecia. The facility currently plans to be 35,000 square feet with adjacent options for growth of over 150,000 square feet.
With this facility Intricon expands its global footprint to 280,000 square feet across seven locations and four countries. The company provides device assembly, custom molding, advanced circuit board and surface mount- assembly, packaging for medical device original equipment manufacturers, and sensor-driven medical devices.
Jorge Herrera is the first key hire at the Costa Rica site as site manager. Herrera will lead the design and construction of the project. Previously he has been integral in Costa Rica building operations for major technology and medical device companies.
Sofia Vargas joins the company from CINDE, the private investment promotion agency of Costa Rica. As business development manager, Vargas has experience with some of the largest medical device companies in Costa Rica and will help guide the company with partnerships and collaborations.
Costa Rica’s Foreign Trade Minister, Manuel Tovar commented, “In recent years, medical devices have become our main export product, making the country a reginal leader and a key ally for companies of the life sciences sector. Today, Intricon, a company dedicated to the development of sensor-driven medical devices, joins this dynamic ecosystem of companies of this sector and announces their entry into one of the most innovative parks of Costa Rica, in 2024. We feel extremely proud about this great news and about providing, together with leading companies like Intericon, positive health outcomes to thousands of people worldwide.”
“Companies need the increased capacity and deep expertise Intricon brings to help them meet the growing demand for sensor-driven devices as non-invasive, data-driven healthcare becomes a reality. When it comes to these devices, Intricon has done it all and seen it all, so we can reduce and eliminate risk while accelerating commercialization,” said CEO Scott Longval.
The facility is scheduled to open in 2024 and will be housed in Costa Rica’s extension zone for medical device infrastructure, Evolution Free Zone, Grecia. The facility currently plans to be 35,000 square feet with adjacent options for growth of over 150,000 square feet.
With this facility Intricon expands its global footprint to 280,000 square feet across seven locations and four countries. The company provides device assembly, custom molding, advanced circuit board and surface mount- assembly, packaging for medical device original equipment manufacturers, and sensor-driven medical devices.
Jorge Herrera is the first key hire at the Costa Rica site as site manager. Herrera will lead the design and construction of the project. Previously he has been integral in Costa Rica building operations for major technology and medical device companies.
Sofia Vargas joins the company from CINDE, the private investment promotion agency of Costa Rica. As business development manager, Vargas has experience with some of the largest medical device companies in Costa Rica and will help guide the company with partnerships and collaborations.
Costa Rica’s Foreign Trade Minister, Manuel Tovar commented, “In recent years, medical devices have become our main export product, making the country a reginal leader and a key ally for companies of the life sciences sector. Today, Intricon, a company dedicated to the development of sensor-driven medical devices, joins this dynamic ecosystem of companies of this sector and announces their entry into one of the most innovative parks of Costa Rica, in 2024. We feel extremely proud about this great news and about providing, together with leading companies like Intericon, positive health outcomes to thousands of people worldwide.”